It is estimated that as many as 85% to 90% of premenopausal women regularly experience affective and/or physical symptoms before the onset of menses.
1 While symptoms are mild in most women, 8% to 20% experience symptoms that meet the clinical definition of premenstrual syndrome (PMS),
1-3 a disorder characterized by moderate to severe symptoms that substantially interfere with normal life activities and interpersonal relationships.
4,5 Symptoms are limited to the luteal phase of the menstrual cycle, abate shortly after the onset of menses, and commonly include depression, irritability, fatigue, abdominal cramping, breast tenderness, and headaches.
1 Women in whom affective symptoms predominate may also meet the criteria for premenstrual dysphoric disorder,
6 a more severe form of PMS that is associated with significant impairment of normal functioning
6,7; recent studies
1,8 estimate that 5% to 8% of premenopausal women meet the criteria for premenstrual dysphoric disorder. Women presenting with symptoms are commonly prescribed oral contraceptives (OCs), gonadotropin-releasing hormone agonists, and serotonin reuptake inhibitors.
9 While these therapies may be effective at treating PMS in many women, they are also associated with substantial adverse effects and can be expensive.
9-11 Alternatives to hormone therapy, such as dietary supplementation, are being evaluated.